- Home
- LUCD vs OCCIM Comparison
LUCD vs OCCIM Comparison
Compare LUCD & OCCIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- OCCIM
- Stock Information
- Founded
- LUCD 2018
- OCCIM N/A
- Country
- LUCD United States
- OCCIM
- Employees
- LUCD N/A
- OCCIM N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OCCIM
- Sector
- LUCD Health Care
- OCCIM
- Exchange
- LUCD Nasdaq
- OCCIM NYSE
- Market Cap
- LUCD N/A
- OCCIM N/A
- IPO Year
- LUCD 2021
- OCCIM N/A
- Fundamental
- Price
- LUCD $1.21
- OCCIM $24.39
- Analyst Decision
- LUCD Strong Buy
- OCCIM
- Analyst Count
- LUCD 4
- OCCIM 0
- Target Price
- LUCD $3.75
- OCCIM N/A
- AVG Volume (30 Days)
- LUCD 1.5M
- OCCIM N/A
- Earning Date
- LUCD 05-12-2025
- OCCIM N/A
- Dividend Yield
- LUCD N/A
- OCCIM N/A
- EPS Growth
- LUCD N/A
- OCCIM N/A
- EPS
- LUCD N/A
- OCCIM N/A
- Revenue
- LUCD $4,346,000.00
- OCCIM N/A
- Revenue This Year
- LUCD $121.84
- OCCIM N/A
- Revenue Next Year
- LUCD $220.91
- OCCIM N/A
- P/E Ratio
- LUCD N/A
- OCCIM N/A
- Revenue Growth
- LUCD 79.00
- OCCIM N/A
- 52 Week Low
- LUCD $0.63
- OCCIM N/A
- 52 Week High
- LUCD $1.80
- OCCIM N/A
- Technical
- Relative Strength Index (RSI)
- LUCD 42.45
- OCCIM N/A
- Support Level
- LUCD $1.07
- OCCIM N/A
- Resistance Level
- LUCD $1.80
- OCCIM N/A
- Average True Range (ATR)
- LUCD 0.13
- OCCIM 0.00
- MACD
- LUCD -0.05
- OCCIM 0.00
- Stochastic Oscillator
- LUCD 19.18
- OCCIM 0.00
About OCCIM OFS CREDIT COMPANY INC 7.875% PREFERRD STCK SERIES F USD25.0
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation primarily through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.